Stay updated on Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.

Latest updates to the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision label was updated to v3.6.5, replacing the previous v3.6.4. This update reflects a new published revision of the page without altering the study information shown.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe study details page version tag was updated from Revision: v3.6.3 to Revision: v3.6.4, reflecting a small backend update to the page. This change does not alter the study information shown to users.SummaryDifference0.0%

- Check45 days agoChange DetectedThe list of study locations was updated to 90 sites, with a new Dallas, Texas (75246) site at Texas Oncology added and several other centers removed.SummaryDifference0.5%

- Check52 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, marking a new iteration of the study record.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s revision label has been updated from Revision: v3.6.0 to Revision: v3.6.2, indicating a new build of the page. This appears to be a minor maintenance update rather than a substantive change to study content.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now indicates recruitment is closed for the study; additional help/navigation links were added and the Intervention/Treatment heading formatting was adjusted.SummaryDifference0.2%

Stay in the know with updates to Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.